Belgium· BE-AMP-SAM429344-00
Glybera
A alipogen tiparvovec product containing alipogene tiparvovec, registered in Belgium by Uniqure Biopharma. The same ATC class is registered in 3 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Alipogen tiparvovec is registered in 3 of 19 countries.
Countries holding a registration under ATC C10AX10 (alipogen tiparvovec), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 3 of them publish a price we can compare per daily dose
Alipogen tiparvovec · ATC C10AX10
3 / 19 countries
- Belgiumprice
- Finlandprice
- Spainprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Alipogene Tiparvovec
- Manufacturer
- Uniqure Biopharma
- Country
- Belgium (BE)
- ATC code
- C10AX10
- ATC class
- Alipogen tiparvovec
- Defined daily dose
- 24 DE, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Alipogen tiparvovec in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cabfe168-3766-42da-9af9-1ecc38f081ea GET /v1/drugs/cabfe168-3766-42da-9af9-1ecc38f081ea?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Glybera",
"name_fr": "Glybera",
"name_nl": "Glybera",
"amp_code": "SAM429344-00",
"strengths": null,
"pack_count": 1,
"substances": [
"Alipogene Tiparvovec"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Alipogene Tiparvovec",
"authorisation_numbers": [
"EU/1/12/791/001"
]
}See everything about alipogen tiparvovec.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.